OXAZOLIDINONE DERIVATIVE, PROCESS OF ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF

Novel oxazolidinone derivatives of the formula I wherein R is a phenyl radical which is unsubstituted or substituted once by CN, H2N-CH2-, A2N-CH2-, H2N-C(=NH)-, H2N-C(=NH)-NH-, H2N-C(=NH)-NH-CH2-, HO-NH-C(=NH)- or HO-NH-C(=NH)-NH-, X is O, S, SO, SO2, -NH- or -NA-, B is A is alkyl having 1 to 6 C a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	JURASZYK HORST DR, BERNOTAT-DANIELOWSKI SABINE DR, WURZIGER HANNS DR, RADDATZ PETER DR, MELZER GUIDO DR, GANTE JOACHIM DR
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Novel oxazolidinone derivatives of the formula I wherein R is a phenyl radical which is unsubstituted or substituted once by CN, H2N-CH2-, A2N-CH2-, H2N-C(=NH)-, H2N-C(=NH)-NH-, H2N-C(=NH)-NH-CH2-, HO-NH-C(=NH)- or HO-NH-C(=NH)-NH-, X is O, S, SO, SO2, -NH- or -NA-, B is A is alkyl having 1 to 6 C atoms, R is H, A, Li, Na, K, NH4 or benzyl, R is H or (CH2)n-COOR , E in each case independently of one another is CH or N, Q is O, S or NH, m is 1, 2 or 3 and n is 0, 1, 2 or 3, and their physiologically acceptable salts inhibit the binding of fibrinogen to the corresponding receptor and can be used for the treatment of thromboses, apoplexy, cardiac infarct, inflammations, arteriosclerosis, osteoporosis and tumours.